HU9203688D0 - Tri-arginine-insuline - Google Patents

Tri-arginine-insuline

Info

Publication number
HU9203688D0
HU9203688D0 HU9203688A HU368892A HU9203688D0 HU 9203688 D0 HU9203688 D0 HU 9203688D0 HU 9203688 A HU9203688 A HU 9203688A HU 368892 A HU368892 A HU 368892A HU 9203688 D0 HU9203688 D0 HU 9203688D0
Authority
HU
Hungary
Prior art keywords
insuline
arginine
tri
Prior art date
Application number
HU9203688A
Other languages
English (en)
Hungarian (hu)
Inventor
James Arthur Hoffmann
Peter Karl Lambooy
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of HU9203688D0 publication Critical patent/HU9203688D0/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HU9203688A 1991-11-26 1992-11-24 Tri-arginine-insuline HU9203688D0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80116391A 1991-11-26 1991-11-26

Publications (1)

Publication Number Publication Date
HU9203688D0 true HU9203688D0 (en) 1993-03-29

Family

ID=25180362

Family Applications (2)

Application Number Title Priority Date Filing Date
HU9203688A HU9203688D0 (en) 1991-11-26 1992-11-24 Tri-arginine-insuline
HU9203688A HUT63457A (en) 1991-11-26 1992-11-24 Process for producing triarginine insulins

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU9203688A HUT63457A (en) 1991-11-26 1992-11-24 Process for producing triarginine insulins

Country Status (17)

Country Link
US (2) US5491216A (OSRAM)
EP (1) EP0544466A1 (OSRAM)
JP (1) JP3304442B2 (OSRAM)
KR (1) KR930009591A (OSRAM)
CN (1) CN1072723A (OSRAM)
AU (1) AU2857692A (OSRAM)
BR (1) BR9204542A (OSRAM)
CA (1) CA2083360A1 (OSRAM)
CZ (1) CZ342492A3 (OSRAM)
FI (1) FI925343L (OSRAM)
HU (2) HU9203688D0 (OSRAM)
IL (1) IL103849A0 (OSRAM)
MX (1) MX9206724A (OSRAM)
NO (1) NO924525L (OSRAM)
NZ (1) NZ245170A (OSRAM)
TW (1) TW224471B (OSRAM)
ZA (1) ZA928916B (OSRAM)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69637130T2 (de) * 1995-02-20 2008-02-21 The Walter And Eliza Hall Institute Of Medical Research, Parkville Immunoreaktive und immunotherapeutische moleküle welche in individuen mit insulin-abhängiger diabetes mellitus interagieren
DK0821006T3 (da) * 1996-07-26 2004-08-16 Aventis Pharma Gmbh Insulinderivater med öget zinkbinding
US6444641B1 (en) 1997-10-24 2002-09-03 Eli Lilly Company Fatty acid-acylated insulin analogs
US6933272B1 (en) 1998-09-22 2005-08-23 Erik Helmerhorst Use of non-peptidyl compounds for the treatment of insulin related ailments
ES2266187T3 (es) 2000-03-24 2007-03-01 Genentech, Inc. Uso de la insulina para el tratamiento de trastornos del cartilago.
MXPA04006084A (es) * 2001-12-20 2005-03-31 Lilly Co Eli Molecula de insulina que tiene una accion en el tiempo prolongada.
EP1620465A2 (en) * 2003-04-29 2006-02-01 Eli Lilly And Company Insulin analogs having protracted time action
WO2007081824A2 (en) * 2006-01-06 2007-07-19 Case Western Reserve University Fibrillation resistant proteins
CN101573133B (zh) 2006-07-31 2014-08-27 诺沃-诺迪斯克有限公司 Peg化延长的胰岛素
PL2074141T3 (pl) 2006-09-22 2017-02-28 Novo Nordisk A/S Analogi insuliny oporne na proteazę
ES2554773T3 (es) 2006-10-04 2015-12-23 Case Western Reserve University Insulina y análogos de la insulina resistentes a la fibrilación
US9387176B2 (en) 2007-04-30 2016-07-12 Novo Nordisk A/S Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
PT2254906T (pt) 2008-03-18 2017-01-03 Novo Nordisk As Análogos de insulina acilados, estabilizados contra proteases
US8993516B2 (en) * 2008-04-14 2015-03-31 Case Western Reserve University Meal-time insulin analogues of enhanced stability
WO2009132129A2 (en) * 2008-04-22 2009-10-29 Case Western Reserve University Isoform-specific insulin analogues
KR20120129875A (ko) * 2008-07-31 2012-11-28 케이스 웨스턴 리저브 유니버시티 염소화 아미노산을 갖는 인슐린 유사체
US9200053B2 (en) 2008-07-31 2015-12-01 Case Western Reserve University Insulin analogues containing penta-fluoro-Phenylalanine at position B24
US8399407B2 (en) * 2009-09-17 2013-03-19 Case Western Reserve University Non-standard insulin analogues
CA2783763A1 (en) 2009-12-11 2011-06-16 Case Western Reserve University Insulin analogues with chlorinated amino acids
US9187547B2 (en) * 2011-03-15 2015-11-17 Novo Nordisk A/S Human insulin analogues and derivatives comprising cysteine substitutions
KR20150002777A (ko) 2012-04-11 2015-01-07 노보 노르디스크 에이/에스 인슐린 제제
RU2673185C2 (ru) 2013-10-07 2018-11-22 Ново Нордиск А/С Новое производное аналога инсулина
CN104017809A (zh) * 2014-06-05 2014-09-03 山东省农业科学院生物技术研究中心 改造的人Insulin蛋白表达基因及表达方法
EP3204410B1 (en) 2014-10-06 2021-01-20 Case Western Reserve University Biphasic single-chain insulin analogues
CA2979397A1 (en) * 2015-03-12 2016-09-15 Board Of Trustees Of Michigan State University Compositions and methods for measuring c-peptide binding and diagnosing immune-mediated diseases
KR20170036643A (ko) * 2015-09-24 2017-04-03 한미약품 주식회사 인슐린의 제조 방법
BR112019011761A2 (pt) 2016-12-16 2019-11-05 Novo Nordisk As composições farmacêuticas contendo insulina

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326473A1 (de) * 1983-07-22 1985-01-31 Hoechst Ag, 6230 Frankfurt Pharmazeutisches mittel zur behandlung des diabetes mellitus
DE3326472A1 (de) * 1983-07-22 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
US4581165A (en) * 1984-06-14 1986-04-08 Eli Lilly And Company Anti-diabetic compounds
US4569792A (en) * 1984-06-14 1986-02-11 Eli Lilly And Company Anti-diabetic compounds
US4569791A (en) * 1984-06-14 1986-02-11 Eli Lilly And Company Anti-diabetic compounds
US5008241A (en) * 1985-03-12 1991-04-16 Novo Nordisk A/S Novel insulin peptides
DK129385A (da) * 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
ZA877505B (en) * 1986-10-14 1989-05-30 Lilly Co Eli Process for transforming a human insulin precursor to human insulin
US4992418A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
EP0347781B1 (de) * 1988-06-23 1994-02-16 Hoechst Aktiengesellschaft Mini-Proinsulin, seine Herstellung und Verwendung
DE3844211A1 (de) * 1988-12-29 1990-07-05 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
DK134189D0 (da) * 1989-03-20 1989-03-20 Nordisk Gentofte Insulinforbindelser
DE3936876A1 (de) * 1989-11-06 1991-05-23 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
US5130236A (en) * 1989-12-07 1992-07-14 Eli Lilly And Company Process for producing des(64,65)-proinsulin
US5139716A (en) * 1990-02-20 1992-08-18 Loral Aerospace Corp. Method of fabricating coolable ceramic structures

Also Published As

Publication number Publication date
CN1072723A (zh) 1993-06-02
MX9206724A (es) 1993-05-01
HUT63457A (en) 1993-08-30
NO924525D0 (no) 1992-11-24
KR930009591A (ko) 1993-06-21
NZ245170A (en) 1994-07-26
TW224471B (OSRAM) 1994-06-01
FI925343A7 (fi) 1993-05-27
NO924525L (no) 1993-05-27
FI925343L (fi) 1993-05-27
AU2857692A (en) 1993-05-27
CZ342492A3 (en) 1993-06-16
JPH05286998A (ja) 1993-11-02
FI925343A0 (fi) 1992-11-25
CA2083360A1 (en) 1993-05-27
JP3304442B2 (ja) 2002-07-22
US5698669A (en) 1997-12-16
US5491216A (en) 1996-02-13
EP0544466A1 (en) 1993-06-02
BR9204542A (pt) 1993-06-01
ZA928916B (en) 1994-05-18
IL103849A0 (en) 1993-04-04

Similar Documents

Publication Publication Date Title
DE69224906D1 (en) Thermotropes flüssig-kristallines segment-blockcopolymer
DE69222933D1 (en) Cholangiographiekatheter
DE59207898D1 (en) Handhobelmaschine
DE69228486D1 (en) Thrombosefilter
DE59208556D1 (en) N-aminopyridonfarbstoffe
HU9203688D0 (en) Tri-arginine-insuline
DE69220944D1 (en) Thyroplastieimplantat
EP0495458A3 (en) Pipe-separator
DE69213016D1 (en) Waescheweichmacher
DE69228857D1 (en) Elastische polyurethanfaser
DE69208351D1 (en) Halovinylderivate
DE69218451D1 (en) Schiffrumpfschwingungsdämpfer
DE69211853D1 (en) Buerstendichtung
DE69213020D1 (en) Squaryliumfarbstoffe
DE59207864D1 (en) Koagulationssonde
DE59209753D1 (en) Spurregelkreis
DE69227453D1 (en) Elektrophotographischer photorezeptor
AU204P (en) NIRIBI Chamelaucium uncinatum
AU205P (en) TARANNA Danthonia richardsonii
AU206P (en) BUNDERRA Danthonia linkii
CA68724S (en) Mobilier-jeu pedagogique
CA69416S (en) Orgnizer
AU352P (en) TRIUMPHANT Chamelaucium uncinatum
CA68506S (en) Pom-pom
CA68731S (en) Moneybox